HIV/AIDS News
Most Popular HIV/AIDS Story
NeurogesX hammered as regulators question HIV-pain app
Shares of NeurogesX, already badly beaten up over the past year, tanked after regulators raised questions about the efficacy of its pain patch for HIV-related pain. Its stock ($NGSX) dropped to as Read more...
Latest Headlines
- February 7, 2012
- December 2, 2011
- December 1, 2011
- November 16, 2011
- September 21, 2011
- September 12, 2011
- May 6, 2011
- February 28, 2011
- January 26, 2011
- December 20, 2010
- December 15, 2010
- November 23, 2010
- November 19, 2010
- September 30, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
